Profil bibliographique

Manon Evain

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

18Publications signalées

158Citations signalées

4Affiliations récentes

Institutions déclarées

Université Paris-Saclay Centre de Recherche des Cordeliers Assistance Publique – Hôpitaux de Paris Hôpital Paul-Brousse

Domaines associés

Hepatocellular Carcinoma Treatment and PrognosisLiver Disease and TransplantationLiver Disease Diagnosis and TreatmentCancer Immunotherapy and BiomarkersProtease and Inhibitor Mechanisms

Publications récentes

2026 articleOpenAlex

Baseline circulating and tumor γδ T cells and early circulating CD8⁺PD1⁺ expansion predict response to Atezolizumab-bevacizumab in HCC

Isabelle Galy–Fauroux, Amna Asif-Laidin, Manon Evain, Joana Gonçalves Araujo et autres

0 citationsClinical Cancer Research

2026 conference-abstractOpenAlex

WED-236 Baseline tumor and circulating gamma/delta T-Cell signatures and early on-treatment CD8+PD-1+ T-Cell expansion predict response to Atezolizumab–Bevacizumab in hepatocellular carcinoma

Isabelle Galy–Fauroux, Amna Asif-Laidin, Manon Evain, Joana Goncalves Araujo et autres

0 citationsJournal of Hepatology

Accès ouvert 2026 articleOpenAlex

Alpha-1 Antitrypsin Deficiency Alleles in Non-Cirrhotic Hepatocellular Carcinoma: Insights from a Multicenter French Cohort

Aurélie Beaufrère, Céline Léon, Marie Decreaker, Laurent Possenti et autres

0 citationsJournal of Clinical and Experimental Hepatology

Accès ouvert 2025 conference-paperOpenAlex

Processus d'identification des individus pour Résil

Manon Evain, Julien Pramil

0 citationsHAL (Le Centre pour la Communication Scientifique Directe)

Accès ouvert 2025 articleOpenAlex

Underdiagnosis of Alpha‐1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study

Manon Evain, Isaac Ruiz, Térésa Antonini, Guillaume Lassailly et autres

3 citationsAlimentary Pharmacology & Therapeutics

2024 articleOpenAlex

Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab

Philippe Sultanik, Claudia Campani, Edouard Larrey, Bertille Campion et autres

21 citationsDigestive and Liver Disease

2023 articleOpenAlex

Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab

Claudia Campani, Ariane Vallot, Haroun Ghannouchi, Manon Allaire et autres

31 citationsHepatology

2023 articleOpenAlex

Complete response with sorafenib after immune-induced hepatitis with atezolizumab/bevacizumab for advanced hepatocellular carcinoma, synergic effect?

Manon Evain, Isabelle Galy–Fauroux, Joana Araujo-Goncalves, Frédéric Charlotte et autres

1 citationClinics and Research in Hepatology and Gastroenterology

2023 articleOpenAlex

Liver Frailty Index is associated with progression-free survival in patients with advanced HCC treated with Atezolizumab/Bevacizumab

Philippe Sultanik, Edouard Larrey, Manon Evain, Bertille Campion et autres

0 citationsJournal of Hepatology

2023 articleOpenAlex

Presence of esophageal varices regardless their size is associated with overall survival in patients with advanced HCC treated with Atezolizumab/Bevacizumab

Philippe Sultanik, Edouard Larrey, Bertille Campion, Manon Evain et autres

0 citationsJournal of Hepatology

2023 articleOpenAlex

Impact of radiological response and pattern of progression on overall survival in patients with hepatocellular carcinoma treated by atezolizumab-bevacizumab

Claudia Campani, Ariane Vallot, Haroun Ghannouchi, Manon Allaire et autres

2 citationsJournal of Hepatology

2023 articleOpenAlex

Alpha-1 antitrypsin deficiency is underdiagnosed in cirrhotic liver transplant patients : a retrospective multicenter study

Manon Evain, Ilias Kounis, Isaac Ruiz, Guillaume Lassailly et autres

0 citationsJournal of Hepatology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.